BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11737340)

  • 1. Kaposi's sarcoma in HIV-infected patients: treatment options.
    Hermans P
    HIV Med; 2000 Jul; 1(3):137-42. PubMed ID: 11737340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kaposi' s sarcoma in HIV-positive patients: the state of art in the HAART-era.
    La Ferla L; Pinzone MR; Nunnari G; Martellotta F; Lleshi A; Tirelli U; De Paoli P; Berretta M; Cacopardo B
    Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2354-65. PubMed ID: 24065230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Update on Kaposi's sarcoma].
    Morand JJ; Lightburn E; Simon F; Patte JH
    Med Trop (Mars); 2007 Apr; 67(2):123-30. PubMed ID: 17691428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Kaposi's sarcoma.
    Von Roenn JH; Cianfrocca M
    Cancer Treat Res; 2001; 104():127-48. PubMed ID: 11191125
    [No Abstract]   [Full Text] [Related]  

  • 5. Kaposi's sarcoma: advances and perspectives.
    Schwartz RA
    J Am Acad Dermatol; 1996 May; 34(5 Pt 1):804-14. PubMed ID: 8632078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
    AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging treatments for epidemic (AIDS-related) Kaposi's sarcoma.
    McGarvey ME; Tulpule A; Cai J; Zheng T; Masood R; Espina B; Arora N; Smith DL; Gill PS
    Curr Opin Oncol; 1998 Sep; 10(5):413-21. PubMed ID: 9800111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the treatment of AIDS-related Kaposi's sarcoma.
    Cattelan AM; Trevenzoli M; Aversa SM
    Am J Clin Dermatol; 2002; 3(7):451-62. PubMed ID: 12180893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy of special HIV-associated diseases: HCV-HIV-co-infection and AIDS-related Kaposi's sarcoma - official satellite to the 7th European Conference on Clinical Aspects and Treatment of HIV-infection, October 23, 1999 in Lisbon, Portugal.
    Goebel FD; Jablonowski H
    Eur J Med Res; 1999 Dec; 4(12):507-13. PubMed ID: 10611054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to liposomal doxorubicin and clinical outcome of HIV-1-infected patients with Kaposi's sarcoma receiving highly active antiretroviral therapy.
    Núñez M; Saballs P; Valencia ME; Santos J; Ferrer E; Santos I; Berrocal A; Galindo MJ; Podzamczer D; Gonzlez-Lahoz J;
    HIV Clin Trials; 2001; 2(5):429-37. PubMed ID: 11673818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Kaposi's sarcoma in HIV-1 infected individuals with emphasis on resource poor settings.
    Dedicoat M; Vaithilingum M; Newton R
    Cochrane Database Syst Rev; 2003; (3):CD003256. PubMed ID: 12917957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prognostic index for AIDS-associated Kaposi's sarcoma in the era of highly active antiretroviral therapy.
    Stebbing J; Sanitt A; Nelson M; Powles T; Gazzard B; Bower M
    Lancet; 2006 May; 367(9521):1495-502. PubMed ID: 16679162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy.
    Cattelan AM; Calabrò ML; De Rossi A; Aversa SM; Barbierato M; Trevenzoli M; Gasperini P; Zanchetta M; Cadrobbi P; Monfardini S; Chieco-Bianchi L
    Int J Oncol; 2005 Sep; 27(3):779-85. PubMed ID: 16077928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical presentations and standard therapy of AIDS-associated Kaposi's sarcoma.
    Von Roenn JH
    Hematol Oncol Clin North Am; 2003 Jun; 17(3):747-62. PubMed ID: 12852654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome.
    Cattelan AM; Calabrò ML; Gasperini P; Aversa SM; Zanchetta M; Meneghetti F; De Rossi A; Chieco-Bianchi L
    J Natl Cancer Inst Monogr; 2001; (28):44-9. PubMed ID: 11158206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ophthalmic manifestations of HIV in the highly active anti-retroviral therapy era.
    Mowatt L
    West Indian Med J; 2013; 62(4):305-12. PubMed ID: 24756590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment.
    Dezube BJ
    Expert Rev Anticancer Ther; 2002 Apr; 2(2):193-200. PubMed ID: 12113241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel pharmacological therapies for the treatment of AIDS-related Kaposi's sarcoma.
    Cattelan AM; Trevenzoli M; Aversa SM
    Expert Opin Investig Drugs; 2004 May; 13(5):501-13. PubMed ID: 15155125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of AIDS-associated Kaposi's sarcoma in Nigerian children: a case series and review of literature.
    Ahmed A; Bugaje MA; Babadoko AA; Ameh E
    J Natl Med Assoc; 2012; 104(7-8):385-9. PubMed ID: 23092054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation recall dermatitis in course of epidemic Kaposi's sarcoma.
    Latini A; Cota C; Ferraresi V; Cordiali-Fei P; Giuliani M; Trento E; Zaccarelli M; Bonadies A; Di Carlo A; Palamara G
    Dermatol Ther; 2013; 26(5):424-7. PubMed ID: 24099075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.